Permeabilization of the outer mitochondrial membrane by Bcl-2 proteins

Advances in Experimental Medicine and Biology

Volumn 677, Issue , 2010, Pages 91-105

  García Sáez, Ana J ^a   Fuertes, Gustavo ^b   Suckale, Jacob ^b   Salgado, Jesús ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; BIM PROTEIN; CARDIOLIPIN; ION CHANNEL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN BID; PROTEIN MCL 1; PROTEIN NOXA; BACTERIAL TOXIN;

ALPHA HELIX; APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CARBOXY TERMINAL SEQUENCE; CELL PERMEABILIZATION; CHANNEL GATING; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; OLIGOMERIZATION; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; ANIMAL; CELL MEMBRANE PERMEABILITY; CHEMICAL MODEL; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW; STRUCTURAL HOMOLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; APOPTOSIS; BACTERIAL TOXINS; CELL MEMBRANE PERMEABILITY; HUMANS; MITOCHONDRIAL MEMBRANES; MODELS, CHEMICAL; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 77955907520     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6327-7_8     Document Type: Article

References (156)

1. Danial NN. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 2007; 13:7254-7263.
2. Chipuk JE, Bouchier-Hayes L, Green DR. Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ 2006; 13:1396-1402. (Pubitemid 44057475)
3. Tsujimoto Y, Cossman J, Jaffe E et al. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228:1440-1443. (Pubitemid 15041322)
4. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize preB-cells. Nature 1988; 335:440-442.
5. Wei MC, Zong WX, Cheng EH et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292:727-730. (Pubitemid 32385543)
6. Li P, Nijhawan D, Budihardjo I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91:479-489. (Pubitemid 27508237)
7. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9:47-59.
8. Johnson JE, Cornell RB. Amphitropic proteins: regulation by reversible membrane interactions (review). Mol Membr Biol 1999; 16:217-235. (Pubitemid 29419697)
9. Hockenbery D, Nunez G, Milliman C et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348:334-336. (Pubitemid 120029101)
10. Gross A, Yin XM, Wang K et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999; 274:1156-1163.
11. Hsu YT, Wolter KG, Youle RJ. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci USA 1997; 94:3668-3672.
12. Wolter KG, Hsu YT, Smith CL et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997; 139:1281-1292. (Pubitemid 27523214)
13. Zha J, Weiler S, Oh KJ et al. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 2000; 290:1761-1765. (Pubitemid 32004806)
14. Chou JJ, Li H, Salvesen GS et al. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 1999; 96:615-624. (Pubitemid 29122804)
15. McDonnell JM, Fushman D, Milliman CL et al. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 1999; 96:625-634. (Pubitemid 29122805)
16. Muchmore SW, Sattler M, Liang H et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 1996; 381:335-341.
17. Suzuki M, Youle RJ, Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 2000; 103:645-654.
18. Day CL, Chen L, Richardson SJ et al. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J Biol Chem 2005; 280:4738-4744. (Pubitemid 40288644)
19. Denisov AY, Madiraju MSR, Chen G et al. Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix. J Biol Chem 2003; 278:21124-21128. (Pubitemid 36806425)
20. Hinds MG, Lackmann M, Skea GL et al. The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J 2003; 22:1497-1507. (Pubitemid 36417399)
21. Moldoveanu T, Liu Q, Tocilj A et al. The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol Cell 2006; 24:677-688. (Pubitemid 44839210)
22. Petros AM, Medek A, Nettesheim DG et al. Solution structure of the antiapoptotic protein bcl-2. Proceedings of the National Academy of Sciences of the United States of America 2001; 98:3012-3017. (Pubitemid 32220791)
23. Petros AM, Olejniczak ET, Fesik SW. Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 2004; 1644:83-94. (Pubitemid 38281265)
24. Lama D, Sankararamakrishnan R. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad and Bim proteins: comparative molecular dynamics simulations. Proteins 2008; 73:492-514.
25. Petros AM, Nettesheim DG, Wang Y et al. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis and biophysical studies. Protein Sci 2000; 9:2528-2534. (Pubitemid 32105735)
26. Sattler M, Liang H, Nettesheim D et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 1997; 275:983-986. (Pubitemid 27087715)
27. Herman MD, Nyman T, Welin M et al. Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim. FEBS Lett 2008; 582:3590-3594.
28. Gavathiotis E, Suzuki M, Davis ML et al. BAX activation is initiated at a novel interaction site. Nature 2008; 455:1076-1081.
29. Hinds MG, Smits C, Fredericks-Short R et al. Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ 2007; 14:128-136. (Pubitemid 44911900)
30. Lazebnik Y. Why do regulators of apoptosis look like bacterial toxins? Curr Biol 2001; 11:R767-R768. (Pubitemid 32930999)
31. Desagher S, Osen-Sand A, Nichols A et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999; 144:891-901. (Pubitemid 29238966)
32. Hsu YT, Youle RJ. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem 1998; 273:10777-10783. (Pubitemid 28227695)
33. Peyerl FW, Dai S, Murphy GA et al. Elucidation of some Bax conformational changes through crystallization of an antibody-peptide complex. Cell Death Differ 2007; 14:447-452.
34. Nechushtan A, Smith CL, Hsu YT et al. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 1999; 18:2330-2341. (Pubitemid 29213267)
35. Garcia-Saez AJ, Mingarro I, Perez-Paya E et al. Membrane-insertion fragments of Bcl-xL, Bax and Bid. Biochemistry 2004; 43:10930-10943. (Pubitemid 39433683)
36. Annis MG, Soucie EL, Dlugosz PJ et al. Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J 2005; 24:2096-2103. (Pubitemid 40961794)
37. Cartron PF, Moreau C, Oliver L et al. Involvement of the N-terminus of Bax in its intracellular localization and function. FEBS Lett 2002; 512:95-100. (Pubitemid 34164458)
38. Nguyen M, Millar DG, Yong VW et al. Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J Biol Chem 1993; 268:25265-25268. (Pubitemid 23358123)
39. Priault M, Camougrand N, Chaudhuri B et al. Role of the C-terminal domain of Bax and Bcl-XL in their localization and function in yeast cells. FEBS Lett 1999; 443:225-228. (Pubitemid 29078637)
40. Ausili A, Torrecillas A, Martínez-Senac MM et al. The interaction of the Bax C-terminal domain with negatively charged lipids modifies the secondary structure and changes its way of insertion into membranes. J Struct Biol 2008; 164:146-152.
41. Mar Martínez-Senac M, Corbalán-García S, Gómez-Fernández JC. Conformation of the C-terminal domain of the pro-apoptotic protein Bax and mutants and its interaction with membranes. Biochemistry 2001; 40:9983-9992. (Pubitemid 32769550)
42. Torrecillas A, Martínez-Senac MM, Ausili A et al. Interaction of the C-terminal domain of Bcl-2 family proteins with model membranes. Biochim Biophys Acta 2007; 1768:2931-2939. (Pubitemid 350060882)
43. Sani MA, Dufourc EJ, Gröbner G. How does the Bax-alpha1 targeting sequence interact with mitochondrial membranes? The role of cardiolipin. Biochim Biophys Acta 2009; 1788:623-631.
44. Qian S, Wang W, Yang L et al. Structure of transmembrane pore induced by Bax-derived peptide: evidence for lipidic pores. Proc Natl Acad Sci USA 2008; 105:17379-17383.
45. Garcia-Saez AJ, Coraiola M, Dalla SM et al. Peptides derived from apoptotic Bax and Bid reproduce the poration activity of the parent full-length proteins. Biophys J 2005; 88:3976-3990. (Pubitemid 40991110)
46. Eskes R, Desagher S, Antonsson B et al. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 2000; 20:929-935. (Pubitemid 30044230)
47. Korsmeyer SJ, Wei MC, Saito M et al. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 2000; 7:1166-1173. (Pubitemid 32042223)
48. Ruffolo SC, Breckenridge DG, Nguyen M et al. BID-dependent and BID-independent pathways for BAX insertion into mitochondria. Cell Death Differ 2000; 7:1101-1108.
49. Wei MC, Lindsten T, Mootha VK et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 2000; 14:2060-2071. (Pubitemid 30637355)
50. Antonsson B, Montessuit S, Lauper S et al. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 2000; 345:271-278. (Pubitemid 30077167)
51. Pagliari LJ, Kuwana T, Bonzon C et al. The multidomain proapoptotic molecules Bax and Bak are directly activated by heat. Proc Natl Acad Sci USA 2005; 102:17975-17980. (Pubitemid 41798487)
52. Tan C, Dlugosz PJ, Peng J et al. Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2. J Biol Chem 2006; 281:14764-14775. (Pubitemid 43855182)
53. Antonsson B, Montessuit S, Sanchez B et al. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 2001; 276:11615-11623.
54. Billen LP, Kokoski CL, Lovell JF et al. Bcl-XL inhibits membrane permeabilization by competing with Bax. PLoS Biol 2008; 6(6):e147.
55. Gross A, Jockel J, Wei MC et al. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998; 17:3878-3885. (Pubitemid 28333974)
56. Hardwick JM, Polster BM. Bax, along with lipid conspirators, allows cytochrome c to escape mitochondria. Mol Cell 2002; 10:963-965. (Pubitemid 35453815)
57. Lovell JF, Billen LP, Bindner S et al. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 2008; 135:1074-1084.
58. Mikhailov V, Mikhailova M, Pulkrabek DJ et al. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 2001; 276:18361-18374.
59. Roucou X, Montessuit S, Antonsson B et al. Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem J 2002; 368:915-921. (Pubitemid 36042694)
60. Saito M, Korsmeyer SJ, Schlesinger PH. BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat Cell Biol 2000; 2:553-555.
61. Valentijn AJ, Upton JP, Gilmore AP. Analysis of endogenous Bax complexes during apoptosis using blue native PAGE: implications for Bax activation and oligomerization. Biochem J 2008; 412:347-357. (Pubitemid 351758241)
62. Kuwana T, Mackey MR, Perkins G et al. Bid, Bax and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002; 111:331-342. (Pubitemid 35341388)
63. Lucken-Ardjomande S, Montessuit S, Martinou JC. Contributions to Bax insertion and oligomerization of lipids of the mitochondrial outer membrane. Cell Death Differ 2008; 15:929-937. (Pubitemid 351524434)
64. Lucken-Ardjomande S, Montessuit S, Martinou JC. Bax activation and stress-induced apoptosis delayed by the accumulation of cholesterol in mitochondrial membranes. Cell Death Differ 2008; 15:484-493. (Pubitemid 351267299)
65. Christenson E, Merlin S, Saito M et al. Cholesterol effects on BAX pore activation. J Mol Biol 2008; 381:1168-11683.
66. Giddings KS, Johnson AE, Tweten RK. Redefining cholesterol's role in the mechanism of the cholesterol-dependent cytolysins. Proc Natl Acad Sci USA 2003; 100:11315-11320. (Pubitemid 37205932)
67. Dlugosz PJ, Billen LP, Annis MG et al. Bcl-2 changes conformation to inhibit Bax oligomerization. EMBO J 2006; 25:2287-2296. (Pubitemid 44012212)
68. Kim PK, Annis MG, Dlugosz PJ et al. During apoptosis bcl-2 changes membrane topology at both the endoplasmic reticulum and mitochondria. Mol Cell 2004; 14:523-529. (Pubitemid 38648805)
69. Thuduppathy GR, Hill RB. Acid destabilization of the solution conformation of Bcl-xL does not drive its pH-dependent insertion into membranes. Protein Sci 2006; 15:248-257. (Pubitemid 43144997)
70. Thuduppathy GR, Craig JW, Kholodenko V et al. Evidence that membrane insertion of the cytosolic domain of Bcl-xL is governed by an electrostatic mechanism. J Mol Biol 2006; 359:1045-1058. (Pubitemid 43831914)
71. Losonczi JA, Olejniczak ET, Betz SF et al. NMR studies of the anti-apoptotic protein Bcl-xL in micelles. Biochemistry 2000; 39:11024-11033.
72. Jeong SY, Gaume B, Lee YJ et al. Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers. EMBO J 2004; 23:2146-2155. (Pubitemid 38737741)
73. O'Neill JW, Manion MK, Maguire B et al. BCL-XL dimerization by three-dimensional domain swapping. J Mol Biol 2006; 356:367-381. (Pubitemid 43099977)
74. Denisov AY, Sprules T, Fraser J et al. Heat-induced dimerization of BCL-xL through alpha-helix swapping. Biochemistry 2007; 46:734-740. (Pubitemid 46133589)
75. Feng Y, Lin Z, Shen X et al. Bcl-xL forms two distinct homodimers at non-ionic detergents: implications in the dimerization of Bcl-2 family proteins. J Biochem 2008; 143:243-252. (Pubitemid 351238168)
76. Zhang Z, Lapolla SM, Annis MG et al. Bcl-2 homodimerization involves two distinct binding surfaces, a topographic arrangement that provides an effective mechanism for Bcl-2 to capture activated Bax. J Biol Chem 2004; 279:43920-43928. (Pubitemid 39390700)
77. Choi SY, Gonzalvez F, Jenkins GM et al. Cardiolipin deficiency releases cytochrome c from the inner mitochondrial membrane and accelerates stimuli-elicited apoptosis. Cell Death Differ 2007; 14:597-606.
78. Esposti MD, Cristea IM, Gaskell SJ et al. Proapoptotic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death. Cell Death Differ 2003; 10:1300-1309. (Pubitemid 37536735)
79. Gonzalvez F, Pariselli F, Dupaigne P et al. tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak. Cell Death Differ 2005; 12:614-626. (Pubitemid 40767164)
80. Gonzalvez F, Bessoule JJ, Rocchiccioli F et al. Role of cardiolipin on tBid and tBid/Bax synergistic effects on yeast mitochondria. Cell Death Differ 2005; 12:659-667. (Pubitemid 40767168)
81. Lutter M, Fang M, Luo X et al. Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol 2000; 2:754-761.
82. Gong XM, Choi J, Franzin CM et al. Conformation of membrane-associated proapoptotic tBid. J Biol Chem 2004; 279:28954-28960. (Pubitemid 38915764)
83. Oh KJ, Barbuto S, Meyer N et al. Conformational changes in BID, a pro-apoptotic BCL-2 family member, upon membrane binding. A site-directed spin labeling study. J Biol Chem 2005; 280:753-767. (Pubitemid 40165044)
84. Schendel SL, Montal M, Reed JC. Bcl-2 family proteins as ion-channels. Cell Death Differ 1998; 5:372-380. (Pubitemid 28356813)
85. Schlesinger PH, Gross A, Yin XM et al. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc Natl Acad Sci USA 1997; 94:11357-11362. (Pubitemid 27451003)
86. Basanez G, Nechushtan A, Drozhinin O et al. Bax, but not Bcl-x(L), decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proc Natl Acad Sci USA 1999; 96:5492-5497. (Pubitemid 29234645)
87. Basanez G, Sharpe JC, Galanis J et al. Bax-type apoptotic proteins porate pure lipid bilayers through a mechanism sensitive to intrinsic monolayer curvature. J Biol Chem 2002; 277:49360-49365. (Pubitemid 36014367)
88. Epand RF, Martinou JC, Montessuit S et al. Transbilayer lipid diffusion promoted by Bax: implications for apoptosis. Biochemistry 2003; 42:14576-14582. (Pubitemid 37532004)
89. Garcia-Saez AJ, Coraiola M, Serra MD et al. Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid pores. Febs Journal 2006; 273:971-981.
90. Terrones O, Antonsson B, Yamaguchi H et al. Lipidic pore formation by the concerted action of proapoptotic BAX and tBID. Journal of Biological Chemistry 2004; 279:30081-30091. (Pubitemid 38937930)
91. Schafer B, Quispe J, Choudhary V et al. Mitochondrial outer membrane proteins assist Bid in Bax-mediated lipidic pore formation. Molecular Biology of the Cell 2009; 20:2276-2285.
92. Jürgensmeier JM, Xie Z, Deveraux Q et al. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 1998; 95:4997-5002. (Pubitemid 28208539)
93. Zha H, Fisk HA, Yaffe MP et al. Structure-function comparisons of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell Biol 1996; 16:6494-6508. (Pubitemid 26361008)
94. Heimlich G, McKinnon AD, Bernardo K et al. Bax-induced cytochrome c release from mitochondria depends on alpha-helices-5 and -6. Biochem J 2004; 378:247-255. (Pubitemid 38299564)
95. Asoh S, Ohtsu T, Ohta S. The super anti-apoptotic factor Bcl-xFNK constructed by disturbing intramolecular polar interactions in rat Bcl-xL. J Biol Chem 2000; 275:37240-37245. (Pubitemid 32002145)
96. Matsuyama S, Schendel SL, Xie Z et al. Cytoprotection by Bcl-2 requires the pore-forming alpha5 and alpha6 helices. J Biol Chem 1998; 273:30995-31001. (Pubitemid 28533104)
97. Nouraini S, Six E, Matsuyama S et al. The putative pore-forming domain of Bax regulates mitochondrial localization and interaction with Bcl-X(L). Mol Cell Biol 2000; 20:1604-1615. (Pubitemid 30100180)
98. Epand RF, Martinou JC, Montessuit S et al. Direct evidence for membrane pore formation by the apoptotic protein Bax. Biochem Biophys Res Commun 2002; 298:744-749. (Pubitemid 35356802)
99. Sobko AA, Kotova EA, Antonenko YN et al. Effect of lipids with different spontaneous curvature on the channel activity of colicin E1: evidence in favor of a toroidal pore. FEBS Lett 2004; 576:205-210. (Pubitemid 39330484)
100. Sobko AA, Kotova EA, Antonenko YN et al. Lipid dependence of the channel properties of a colicin E1-lipid toroidal pore. J Biol Chem 2006; 281:14408-1446.
101. Lee MT, Hung WC, Chen FY et al. Mechanism and kinetics of pore formation in membranes by water-soluble amphipathic peptides. Proc Natl Acad Sci USA 2008; 105:5087-5092.
102. Huang HW. Free energies of molecular bound States in lipid bilayers: lethal concentrations of antimicrobial peptides. Biophys J 2009; 96:3263-3272.
103. Garcia-Saez AJ, Chiantia S, Salgado J et al. Pore formation by a Bax-derived peptide: Effect on the line tension of the membrane probed by AFM. Biophys J 2007; 93:103-112. (Pubitemid 47041655)
104. Minn AJ, Velez P, Schendel SL et al. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature 1997; 385:353-357.
105. Thuduppathy GR, Terrones O, Craig JW et al. The N-terminal domain of Bcl-xL reversibly binds membranes in a pH-dependent manner. Biochemistry 2006; 45:14533-14542. (Pubitemid 44865207)
106. Peng J, Tan C, Roberts GJ et al. tBid elicits a conformational alteration in membrane-bound Bcl-2 such that it inhibits Bax pore formation. J Biol Chem 2006; 281:35802-35811. (Pubitemid 46041312)
107. Peng J, Lapolla SM, Zhang Z et al. The cytosolic domain of Bcl-2 forms small pores in model mitochondrial outer membrane after acidic pH-induced membrane association. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2009; 26:130-137.
108. Basanez G, Zhang J, Chau BN et al. Pro-apoptotic cleavage products of Bcl-x(L) form cytochrome c-conducting pores in pure lipid membranes. J Biol Chem 2001; 276:31083-31091.
109. Cheng EH, Kirsch DG, Clem RJ et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278:1966-1968. (Pubitemid 28013242)
110. Jonas EA, Hickman JA, Chachar M et al. Proapoptotic N-truncated BCL-xL protein activates endogenous mitochondrial channels in living synaptic terminals. Proc Natl Acad Sci USA 2004; 101:13590-13595. (Pubitemid 39238447)
111. Lin B, Kolluri SK, Lin F et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004; 116:527-540. (Pubitemid 38264430)
112. Wei MC, Lindsten T, Mootha VK et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 2000; 14:2060-2071. (Pubitemid 30637355)
113. Zong WX, Lindsten T, Ross AJ et al. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 2001; 15:1481-1486. (Pubitemid 32552527)
114. Epand RF, Martinou JC, Fornallaz-Mulhauser M et al. The apoptotic protein tBid promotes leakage by altering membrane curvature. J Biol Chem 2002; 277:32632-32639. (Pubitemid 34984768)
115. Kudla G, Montessuit S, Eskes R et al. The destabilization of lipid membranes induced by the C-terminal fragment of caspase 8-cleaved bid is inhibited by the N-terminal fragment. J Biol Chem 2000; 275:22713-22718. (Pubitemid 30646152)
116. Schendel SL, Azimov R, Pawlowski K et al. Ion channel activity of the BH3 only Bcl-2 family member, BID. J Biol Chem 1999; 274:21932-21936.
117. Yan L, Miao Q, Sun Y et al. tBid forms a pore in the liposome membrane. FEBS Lett 2003; 555:545-550. (Pubitemid 37532608)
118. Epand RF, Martinou JC, Fornallaz-Mulhauser M et al. The apoptotic protein tBid promotes leakage by altering membrane curvature. J Biol Chem 2002; 277:32632-32639. (Pubitemid 34984768)
119. Esposti MD, Erler JT, Hickman JA et al. Bid, a widely expressed proapoptotic protein of the Bcl-2 family, displays lipid transfer activity. Mol Cell Biol 2001; 21:7268-7276. (Pubitemid 32953480)
120. Esposti MD. The roles of Bid. Apoptosis 2002; 7:433-440.
121. Grad JM, Zeng XR, Boise LH. Regulation of Bcl-xL: a little bit of this and a little bit of STAT. Curr Opin Oncol 2000; 12:543-549. (Pubitemid 32039653)
122. Gardai SJ, Hildeman DA, Frankel SK et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 2004; 279:21085-21095. (Pubitemid 38656511)
123. Kim BJ, Ryu SW, Song BJ. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 2006; 281:21256-21265.
124. Linseman DA, Butts BD, Precht TA et al. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 2004; 24:9993-10002. (Pubitemid 39463581)
125. Zhong Q, Gao W, Du F et al. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005; 121:1085-1095. (Pubitemid 40884398)
126. Akiyama T, Bouillet P, Miyazaki T et al. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J 2003; 22:6653-6664. (Pubitemid 38009611)
127. Tran SE, Meinander A, Eriksson JE. Instant decisions: transcription-independent control of death-receptor-mediated apoptosis. Trends Biochem Sci 2004; 29:601-608. (Pubitemid 39389080)
128. Oda E, Ohki R, Murasawa H et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288:1053-1058. (Pubitemid 30324238)
129. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7:683-694. (Pubitemid 32706359)
130. Dijkers PF, Medema RH, Lammers JW et al. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 2000; 10:1201-1204.
131. Li H, Zhu H, Xu CJ et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94:491-501. (Pubitemid 28391865)
132. Zha J, Harada H, Yang E et al. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996; 87:619-628. (Pubitemid 26386936)
133. Ley R, Ewings KE, Hadfield K et al. Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ 2005; 12:1008-10014.
134. Puthalakath H, Huang DC, O'Reilly LA et al. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 1999; 3:287-296. (Pubitemid 29290669)
135. Puthalakath H, Villunger A, O'Reilly LA et al. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 2001; 293:1829-1832. (Pubitemid 32845780)
136. Goping IS, Gross A, Lavoie JN et al. Regulated targeting of BAX to mitochondria. J Cell Biol 1998; 143:207-215. (Pubitemid 28480529)
137. Yethon JA, Epand RF, Leber B et al. Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis. J Biol Chem 2003; 278:48935-48941.
138. Mikhailov V, Mikhailova M, Degenhardt K et al. Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome c release. J Biol Chem 2003; 278:5367-5376. (Pubitemid 36801053)
139. Willis SN, Fletcher JI, Kaufmann T et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007; 315:856-859.
140. Willis SN, Chen L, Dewson G et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 2005; 19:1294-1305. (Pubitemid 41003019)
141. Zhou L, Chang DC. Dynamics and structure of the Bax-Bak complex responsible for releasing mitochondrial proteins during apoptosis. J Cell Sci 2008; 121:218621-96.
142. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74:609-619. (Pubitemid 23259742)
143. Korsmeyer SJ, Shutter JR, Veis DJ et al. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993; 4:327-332. (Pubitemid 2028596)
144. Veis DJ, Sorenson CM, Shutter JR et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 1993; 75:229-240. (Pubitemid 23320287)
145. Motoyama N, Wang F, Roth KA et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995; 267:1506-1510.
146. Shindler KS, Latham CB, Roth KA. Bax deficiency prevents the increased cell death of immature neurons in bcl-x-deficient mice. J Neurosci 1997; 17:3112-3119. (Pubitemid 27175823)
147. Chen L, Willis SN, Wei A et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17:393-403. (Pubitemid 40193310)
148. Nijhawan D, Fang M, Traer E et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003; 17:1475-1486. (Pubitemid 36734705)
149. Hausmann G, O'Reilly LA, van Driel R et al. Pro-apoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-x(L). J Cell Biol 2000; 149:623-634.
150. Wilson-Annan J, O'Reilly LA, Crawford SA et al. Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J Cell Biol 2003; 162:877-887. (Pubitemid 37087727)
151. Leber B, Lin J, Andrews DW. Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis 2007; 12:897-911. (Pubitemid 46653294)
152. Leu JI, Dumont P, Hafey M et al. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004; 6:443-450. (Pubitemid 38607505)
153. Kuwana T, Bouchier-Hayes L, Chipuk JE et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 2005; 17:525-535. (Pubitemid 40269117)
154. Terrones O, Etxebarria A, Landajuela A et al. BIM and tBID are not mechanistically equivalent when assisting BAX to permeabilize bilayer membranes. J Biol Chem 2008; 283:7790-7803.
155. Chipuk JE, Fisher JC, Dillon CP et al. Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci USA 2008; 105, 20327-20332..
156. Jaysinghe S, Hristova K, Wimley W et al. http://blanco.biomol.uci.edu/ mpex. 2008.